Skip to content

Knowledge Center

Episode 271- The Price at the Pharmacy: Why Real-Time Prescription Transparency Remains Out of Reach

June 8, 2022

This joint letter was sent to HHS Secretary Xavier Becerra from the HIPAA-designated Standards Development Organizations and Operating Rules Entity (CAQH Committee on Operating Rules for Information Exchange, Health Level Seven, National Council for Prescription Drug Programs, Workgroup for Electronic Data Interchange, and X12). The letter represents a consensus on a number of critical administrative transactions issues.

Use the link below to read the full comment letter.

Scroll To Top